Zimmer/Centerpulse Merger Would Build Minimally-Invasive Surgery Portfolio
This article was originally published in The Gray Sheet
Executive Summary
Centerpulse's allogenic bone concentrate (ABC) would give Zimmer a spine fusion product to compete directly with Medtronic Sofamor Danek's InFuse bone graft/LT-CAGE lumbar tapered fusion device
You may also be interested in...
Zimmer Rounds Out Spinal Offerings With Abbott Spine Acquisition
Zimmer's $360 million acquisition of Abbott's spinal surgery business will add pedicle screws and an interspinous stabilizer system to help round out Zimmer's own spinal offerings and create "critical mass" in the spinal business, the company says
Zimmer Rounds Out Spinal Offerings With Abbott Spine Acquisition
Zimmer's $360 million acquisition of Abbott's spinal surgery business will add pedicle screws and an interspinous stabilizer system to help round out Zimmer's own spinal offerings and create "critical mass" in the spinal business, the company says
Zimmer’s Endius Purchase Is “Part One” Of Spinal Device Acquisition Plan
Zimmer's purchase of minimally invasive spinal surgery system maker Endius fills a key gap in the firm's spinal portfolio and represents a first step in a broader spinal acquisition strategy, Zimmer says